| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 10/20/2004 | EP1468680A2 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| 10/20/2004 | EP1468020A2 Multimers of receptor-binding ligands |
| 10/20/2004 | EP1468019A2 Secreted protein |
| 10/20/2004 | EP1468018A2 Leptin proteins |
| 10/20/2004 | EP1467994A1 Pteridine derivatives, method for the production thereof, and use thereof |
| 10/20/2004 | EP1467982A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof |
| 10/20/2004 | EP1467976A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 10/20/2004 | EP1467972A1 Indazole compounds useful as protein kinase inhibitors |
| 10/20/2004 | EP1467752A1 HUMAN MAST CELL−EXPRESSED MEMBRANE PROTEINS |
| 10/20/2004 | EP1467749A1 Thrombin derived peptides for promoting cardiac tissue repair |
| 10/20/2004 | EP1467741A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 10/20/2004 | EP1467740A1 Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases |
| 10/20/2004 | EP1467739A2 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 10/20/2004 | EP1467735A2 Polymorphs of clopidogrel hydrogensulfate |
| 10/20/2004 | EP1467734A1 Cotherapy with an oxazolidinone and a vitamin b |
| 10/20/2004 | EP1467732A1 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases |
| 10/20/2004 | EP1467731A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
| 10/20/2004 | EP1467721A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 10/20/2004 | EP1467714A1 Drug mixture with enhanced dissolution rate |
| 10/20/2004 | EP1465643A4 Methods and compositions for oxygen transport comprising a high oxygen affinity |
| 10/20/2004 | EP1263725B1 Novel compounds |
| 10/20/2004 | EP1232252A4 Reversibly inactivated acidified plasmin |
| 10/20/2004 | EP1230236B1 Compound with growth hormone releasing properties |
| 10/20/2004 | EP1206268B1 Novel compositions for controlled release of a biologically active agent, and the preparation thereof |
| 10/20/2004 | EP1140941B1 Nitrogen containing heterobicycles as factor xa inhibitors |
| 10/20/2004 | CN1538972A 腺苷a3受体激动剂 A3 adenosine receptor agonists |
| 10/20/2004 | CN1538966A 喹唑啉酮衍生物 Quinazolinone derivatives |
| 10/20/2004 | CN1538959A Fused-polycyclic compounds |
| 10/20/2004 | CN1538955A Pyrrolidine derivatives as factor Xa inhibitors |
| 10/20/2004 | CN1538848A Novel Benzo-fused heterocycles |
| 10/20/2004 | CN1538845A Phenyl derivatives as factor Xa inhibitors |
| 10/20/2004 | CN1538836A Substituted amine derivatives and method of use |
| 10/20/2004 | CN1537628A Purpleblow maple lozenge for health-care,and its prepn. method |
| 10/20/2004 | CN1537605A Herbal medicine for eliminating dandruff |
| 10/20/2004 | CN1537580A Honghua Qili tablet contg. safflower carthamus, and its prepn. method |
| 10/20/2004 | CN1537575A Granule contg. Radix astragalic, donkey-hide gelatin, rattletop and others for increasing leucocyte and its prepn. method |
| 10/20/2004 | CN1537572A Qili dispersing tablet for treating traumatic injuries, and its prepn. method |
| 10/20/2004 | CN1537570A Application of Ypsilandra herbs for preparing medicines for treating hemorrhagic diseases |
| 10/20/2004 | CN1537558A Traditional Chinese medicine for treating blood viscosity |
| 10/20/2004 | CN1537542A Donkey-hide gelatin syrup |
| 10/20/2004 | CN1537532A Pyridoxin and application of its derivatives in preparation of medicine |
| 10/20/2004 | CN1537531A Celecoxib compositions |
| 10/20/2004 | CN1171997C Modified TLE-2-receptor ligands |
| 10/20/2004 | CN1171889C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase |
| 10/20/2004 | CN1171883C Nonsteroidal antiinflammatories |
| 10/20/2004 | CN1171858C Polyasparacyl-L-arginine, its preparation and medical application |
| 10/20/2004 | CN1171610C Traditional Chinese medcine injection for curing cardiovascular and cerebrovascular diseases and fundus disease and its preparing method |
| 10/19/2004 | US6806360 Nucleic acids encoding human tissue factor inhibitor |
| 10/19/2004 | US6806262 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds |
| 10/19/2004 | US6806063 Protein conjugate for use in the treatment of blood disorder |
| 10/19/2004 | US6805863 Comprises antibodies/proteins providing inhibition of prothrombinase; treatment and prevention of bacterial and viral infections, allograft/xenograft rejection, glomerulo-nephritis, cancer, gastrointestinal diseases, and fetal loss |
| 10/19/2004 | CA1341459C Modified fibrinolytic enzymes |
| 10/18/2004 | CA2426115A1 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
| 10/14/2004 | WO2004087763A1 Modified antibody against cd22 and utilization thereof |
| 10/14/2004 | WO2004087727A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 10/14/2004 | WO2004087696A1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses |
| 10/14/2004 | WO2004087695A1 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products |
| 10/14/2004 | WO2004087646A2 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases |
| 10/14/2004 | WO2004087172A1 T-type calcium channel blockers |
| 10/14/2004 | WO2004071392A8 Diagnostics and therapeutics for diseases associated with acetylcholine receptor, muscarinic 4(m4) |
| 10/14/2004 | WO2004050636A3 IMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 10/14/2004 | WO2004044229A3 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A2 (PDE7a2) |
| 10/14/2004 | WO2004042402A3 Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) |
| 10/14/2004 | WO2004042076A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4a (pde4a) |
| 10/14/2004 | WO2004024875A8 Mammalian megakaryocyte progenitor cell |
| 10/14/2004 | WO2003104282A3 Glycoprotein vi - fc fusion protein for treating vascular disorders |
| 10/14/2004 | US20040204482 provides a defined blood concentration profile having no rapid initial rise in blood plasma concentration of the good soluble active substance when administered; (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide; nervous system, gastrointestinal, heart disorders, Alzheimer's |
| 10/14/2004 | US20040204481 Activation of natural killer cells by adenosine A3 receptor agonists |
| 10/14/2004 | US20040204464 Isoxazoline compounds having MIF antagonist activity |
| 10/14/2004 | US20040204436 Imidazonaphthyridines |
| 10/14/2004 | US20040204425 Sodium channel blockers |
| 10/14/2004 | US20040204424 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for therapy of chronic bronchitis, emphysema, cystic fibrosis, and eye disorders |
| 10/14/2004 | US20040204418 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease |
| 10/14/2004 | US20040204368 Oxadiazole derivative compounds and drugs containing these compounds as the active ingredient |
| 10/14/2004 | US20040204345 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening |
| 10/14/2004 | US20040203118 Polynucleotides and polypeptides of the IFNalpha-14 gene |
| 10/14/2004 | US20040202899 alumina, silica or titania, an element or compound of platinum, palladium, iridium or rhodium; colloidal dispersions are mixed and blended with synthetic polymers and spun into filaments or hollow fibers; clothing and bedding; anticoagulants |
| 10/14/2004 | US20040202659 A polypeptide encoded by a nucleic acid that encodes a heavy chain, which is able to bind to GPIIb/IIIa, of a human antibody and comprising a CDR3 region; diagnosis, treatment or prevention of autoimmune thrombocytopenic purpura; modulating blood coagulation |
| 10/14/2004 | CA2520894A1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses |
| 10/13/2004 | EP1466968A2 Method and apparatus for encapsulation of biologically-active substances |
| 10/13/2004 | EP1466915A1 Porphyrin compound, albumin inclusion compound thereof and artificial oxygen carrier |
| 10/13/2004 | EP1466912A1 2-acylaminothiazole derivative or salt thereof |
| 10/13/2004 | EP1466649A1 Pharmaceutical composition containing artificial oxygen carrier |
| 10/13/2004 | EP1466615A1 Pharmaceutical composition |
| 10/13/2004 | EP1466608A1 Herbal composition comprising Angelica gigantis, Cnidium officinale and Paeonia japonica |
| 10/13/2004 | EP1465983A2 Endothelial stem cells, populations, methods of isolation and use thereof |
| 10/13/2004 | EP1465924A2 Modulators of notch ic protease activity for use in immunotherapy |
| 10/13/2004 | EP1465900A1 Rho-kinase inhibitors |
| 10/13/2004 | EP1465892A1 Glycinamides as factor xa inhibitors |
| 10/13/2004 | EP1465891A2 Inhibitors of dipeptidyl peptidase iv |
| 10/13/2004 | EP1465889A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 10/13/2004 | EP1465867A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 10/13/2004 | EP1465866A2 Protease inhibitors of the coagulation cascade isolated from dysidea sponges |
| 10/13/2004 | EP1465864A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 10/13/2004 | EP1465666A2 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy |
| 10/13/2004 | EP1465654A2 Plasmid mediated suplementation for treating chronically ill subjects |
| 10/13/2004 | EP1465643A1 Methods and compositions for oxygen transport comprising a high oxygen affinity |
| 10/13/2004 | EP1465624A1 Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof |
| 10/13/2004 | EP1465592A2 Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| 10/13/2004 | EP1397137A4 Hydantion derivatives as inhibitors of matrix metalloproteinases |